-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Cullinan Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from Q1 2020 to 2024.
- Cullinan Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Dec 2023 was -$14.1M, a 660% decline year-over-year.
- Cullinan Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending 31 Dec 2023 was -$14.1M, a 134% decline year-over-year.
- Cullinan Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $117K.
- Cullinan Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$14.1M, a 134% decline from 2022.
- Cullinan Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $42.1M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)